These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2801317)

  • 1. Inhibitory effects of E-5110 on interleukin-1 generation from human monocytes.
    Shirota H; Goto M; Hashida R; Yamatsu I; Katayama K
    Agents Actions; 1989 Jun; 27(3-4):322-4. PubMed ID: 2801317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inhibitor of IL-1 generation, E5090: in vitro inhibitory effects on the generation of IL-1 by human monocytes.
    Goto M; Chiba K; Hashida R; Shirota H
    Agents Actions Suppl; 1991; 32():225-9. PubMed ID: 2069091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.
    Lee JC; Griswold DE; Votta B; Hanna N
    Int J Immunopharmacol; 1988; 10(7):835-43. PubMed ID: 3148560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6.
    Tanaka K; Aikawa Y; Kawasaki H; Asaoka K; Inaba T; Yoshida C
    J Pharmacobiodyn; 1992 Nov; 15(11):649-55. PubMed ID: 1289500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugs.
    Rordorf-Adam C; Lazdins J; Woods-Cook K; Alteri E; Henn R; Geiger T; Feige U; Towbin H; Erard F
    Drugs Exp Clin Res; 1989; 15(8):355-62. PubMed ID: 2513175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production.
    Glaser KB; Lock YW
    Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.
    Hartman DA; Ochalski SJ; Carlson RP
    Inflamm Res; 1995 Jul; 44(7):269-74. PubMed ID: 8564522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the novel non-steroidal antiinflammatory agent N-methoxy-3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2-one on in vitro generation of some inflammatory mediators.
    Shirota H; Kobayashi S; Terato K; Sakuma Y; Yamada K; Ikuta H; Yamagishi Y; Yamatsu I; Katayama K
    Arzneimittelforschung; 1987 Aug; 37(8):936-40. PubMed ID: 2823844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of N-methoxy-3-(3,5-ditert-butyl-4-hydroxybenzylidene)-2-pyrrolidon e (E-5110), a novel nonsteroidal antiinflammatory agent, on generation of some inflammatory mediators.
    Katayama K; Shirota H; Kobayashi S; Terato K; Ikuta H; Yamatsu I
    Agents Actions; 1987 Aug; 21(3-4):269-71. PubMed ID: 2825479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of non-steroidal anti-inflammatory drugs on the accumulation and release of interleukin-1-like activity by peritoneal macrophages from the mouse.
    Bahl AK; Dale MM; Foreman JC
    Br J Pharmacol; 1994 Nov; 113(3):809-14. PubMed ID: 7858871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of SK&F 86002 on monocyte IL-1 production.
    Lee JC; Votta B; Griswold DE; Hanna N
    Agents Actions; 1989 Jun; 27(3-4):280-1. PubMed ID: 2801311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs.
    Fiorucci S; Santucci L; Cirino G; Mencarelli A; Familiari L; Soldato PD; Morelli A
    J Immunol; 2000 Nov; 165(9):5245-54. PubMed ID: 11046058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes.
    Chang DM; Baptiste P; Schur PH
    J Rheumatol; 1990 Sep; 17(9):1148-57. PubMed ID: 1981242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
    Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
    Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro.
    Hoffman T; Lee YL; Lizzio EF; Tripathi AK; Jessop JJ; Taplits M; Abrahamsen TG; Carter CS; Puri J
    Clin Immunol Immunopathol; 1991 Mar; 58(3):399-408. PubMed ID: 1900463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase.
    Profita M; Sala A; Siena L; Henson PM; Murphy RC; Paternò A; Bonanno A; Riccobono L; Mirabella A; Bonsignore G; Vignola AM
    J Pharmacol Exp Ther; 2002 Mar; 300(3):868-75. PubMed ID: 11861792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effect of anti-rheumatic drugs on interleukin-1 beta release from human peripheral blood monocytes.
    Okamoto M; Sasano M; Goto M; Nishioka K; Aotsuka S; Nakamura K; Yokohari R
    Int J Immunopharmacol; 1991; 13(1):39-43. PubMed ID: 2026474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis.
    Otterness IG; Bliven ML; Downs JT; Natoli EJ; Hanson DC
    Cytokine; 1991 Jul; 3(4):277-83. PubMed ID: 1873477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.